In the original version of this article (1), the name of the sixth author, Rosa J. Lee-Alonzo, is incorrect. The name has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
Reference
1.
Donaldson
JM
,
Seddiq
M
,
Fusco
MJ
,
Singla
S
,
Pamuk
GE
,
Lee-Alonzo
RJ
,
et al.
Highlights of FDA oncology approvals in 2023: bispecific T-cell engagers, pediatric indications, and inclusive drug development
. Cancer Discov
2023
;13
:2515
–24
.©2024 American Association for Cancer Research
2024
American Association for Cancer Research
RSS Feeds